Skip to main content

Animations

MJFF Publications

3891 - 3900 of 8818 Results
Title
Year
  • Year
  • 2009
  • 2020
  • 2017
  • 2013
  • 2025
  • 2016
  • 2012
  • 2017
  • 2017
  • 2018
  • Summary Details
    OPEN
    Title: Ceramide and neurodegeneration: Susceptibility of neurons and oligodendrocytes to cell damage and death
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2008.12.010
    Citation Count: 225
  • Summary Details
    OPEN
    Title: Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4+, CD8+ T cells, and M1 macrophages
    Journal Name: Journal for ImmunoTherapy of Cancer
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1136/jitc-2020-001617
    Citation Count: 44
  • Summary Details
    OPEN
    Title: Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s disease
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1616874114
    Citation Count: 79
  • Summary Details
    RESTRICTED
    Title: 5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2013.08.014
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Synaptic vesicle endocytosis deficits underlie cognitive dysfunction in mouse models of GBA-linked Parkinson’s disease and dementia with Lewy bodies
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41467-025-63444-9
    Citation Count: 0
  • Summary Details
    OPEN
    Title: ALS‐linked protein disulfide isomerase variants cause motor dysfunction
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.15252/embj.201592224
    Citation Count: 108
  • Summary Details
    OPEN
    Title: Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2012.11.007
    Citation Count: 67
  • Summary Details
    RESTRICTED
    Title: Square biphasic pulse deep brain stimulation for essential tremor: The BiP tremor study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.10.015
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic Hypotension
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12478
    Citation Count: 76
  • Summary Details
    RESTRICTED
    Title: Normal and pathological neuronal distribution of the human mesencephalic locomotor region
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27578
    Citation Count: 35
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.